Denali Therapeutics Inc. Public Float
Denali Therapeutics Inc. (DNLI) had Public Float of $1.10 billion as of 2025-06-30, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-02-26
- 2025-06-30: Entity Public Float $1.10B.
- 2024-06-28: Entity Public Float $1.90B.
- 2023-06-30: Entity Public Float $2.00B.
- 2022-06-30: Entity Public Float $1.50B.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $1.10B 10-K · filed 2026-02-26 |
| 2024-06-28 | $1.90B 10-K · filed 2025-02-27 |
| 2023-06-30 | $2.00B 10-K · filed 2024-02-28 |
| 2022-06-30 | $1.50B 10-K · filed 2023-02-27 |
| 2021-06-30 | $2.80B 10-K · filed 2022-02-28 |
| 2020-06-30 | $850.60M 10-K · filed 2021-02-26 |
| 2019-06-28 | $715.60M 10-K · filed 2020-02-27 |
| 2018-06-29 | $489.40M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |